Henriëtte Lanz,
Director, Model Development
Henriette Lanz is Director of the Model Development R&D team at Mimetas. She has received her PhD in Molecular Biology from Leiden University in 2012, and a cum laude masters in Life Science Technologies. She worked on cancer-selective target discovery at Leiden University and secondary metabolite production at Explant Technologies. In her current role at Mimetas she supervises a team of senior and junior scientists and technicians, alongside PhD and MSc students. The specific focus of her research activities at Mimetas are the development of organotypic models for drug screening and toxicity evaluation within the fields of kidney, vasculature, and cancer.
|
|
|
